GLP-1 (Glucagon-Like Peptide-1) agonists are a group of drugs which, in their action, have both blood sugar reduction and weight loss due to their mimicry of the natural GLP-1 hormone in the body. These drugs are almost similar to the natural GLP-1 hormone in the body. The purpose of this article is to analyze these with reference to the dosages, the medications, and the effects:
1. Semaglutide
-
- Brand names: Ozempic (diabetes), Wegovy (obesity)
-
- Administration: A single weekly subcutaneous dose
-
- Likspan for weight drawings
2. Liraglutide
-
- Brand names: Victoza (for diabetes), Saxenda (for weight loss)
-
- Administration: Daily injection
-
- Acts on both glycemic and weight regulation.
3. Dulaglutide
-
- Drugname: Trulicity (ELI LILLY AND COMPANY)
-
- Administration: Weekly injection
-
- Firstly, even if fatigue-related side effects are present, such a medication that would be ascribing might be helpful in solving them.
4. Exenatide
-
- Brand names: Byetta (short-acting), Bydureon (long-acting)
-
- Administration: Twice daily (Byetta) or weekly (Bydureon) injection
-
- Treatment contained various GLP-1 agonists as one of the potential options.
5. Lixisenatide
-
- Brand name: Adlyxin
-
- Administration: Daily injection
-
- The preparation is used for the control of type 2 diabetes mellitus.
These medicines have their profile in terms of effectiveness, frequency of dosing, and potential side effects of each one. The final decision on the choice of the GLP-1 agonist to be taken by the patient is regated based on individual patient factors, such as the severity of their medical conditions, the specific therapies they are already receiving, and, of course, their ability to cope with the prescribed drugs or the side effects of the drugs.
0 Comments